目的:观察和血明目片对视网膜静脉阻塞所致眼底出血的临床疗效。方法:将视网膜静脉阻塞所致眼底出血的患者78例82眼随机分为治疗组38例40眼、对照组40例42眼,治疗组患者服用和血明目片进行治疗,对照组患者服用VC、芦丁以及阿司匹林进行治疗,共分为2个疗程。结果:治疗组患者视网膜出血显著吸收,疗效明显高于对照组,差异具有统计学意义(P<0.05)。结论:和血明目片治疗视网膜静脉阻塞所致眼底出血疗效显著。

AIM:To observe the clinical efficacy of hexuemingmu tablet for retinal hemorrhage caused by retinal vein occlusion. ·METHODS:Totally 78 patients 82 eyes with retinal hemorrhage caused by retinal vein occlusion were randomly divided into two groups:the treatment group(38 cases,40 eyes) and the control group(40 cases,42 eyes).The treatment group was given hexuemingmu tablet,the control group was given VC,rutin and aspirin.All patients underwent the drug therapy for 2 periods.·RESULTS:Compared with the control group,retinal hemorrhage was obviously absorbed in the treatment group,and the difference was statistically significant (P<0.01).·CONCLUSION:Hexuemingmu tablet is an effective drug for retinal hemorrhage caused by retinal vein occlusion.

R276.7